NOVATO, Calif., July 11, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq:RPTP), today provided an update on the Company’s business and announced financial results for the third quarter ended May 31, 2012.
NOVATO, Calif., July 11, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq:RPTP), today provided an update on the Company’s business and announced financial results for the third quarter ended May 31, 2012.